Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Section I Schizophrenia
- 1 Structural imaging of schizophrenia
- 2 Functional imaging of schizophrenia
- 3 Spectroscopic imaging of schizophrenia
- 4 Neuroreceptor imaging of schizophrenia
- 5 Neuroimaging of schizophrenia: commentary
- Section II Mood Disorders
- Section III Anxiety Disorders
- Section IV Cognitive Disorders
- Section V Substance Abuse
- Section VI Eating Disorders
- Section VII Developmental Disorders
- Index
- References
2 - Functional imaging of schizophrenia
from Section I - Schizophrenia
Published online by Cambridge University Press: 10 January 2011
- Frontmatter
- Contents
- List of contributors
- Preface
- Section I Schizophrenia
- 1 Structural imaging of schizophrenia
- 2 Functional imaging of schizophrenia
- 3 Spectroscopic imaging of schizophrenia
- 4 Neuroreceptor imaging of schizophrenia
- 5 Neuroimaging of schizophrenia: commentary
- Section II Mood Disorders
- Section III Anxiety Disorders
- Section IV Cognitive Disorders
- Section V Substance Abuse
- Section VI Eating Disorders
- Section VII Developmental Disorders
- Index
- References
Summary
Introduction
Functional magnetic resonance imaging (fMRI) neuroimaging investigations in schizophrenia have been used for a variety of purposes. These include shedding light on the underlying pathophysiology of the illness, understanding the neural basis of characteristic symptoms, aiding with diagnostic classification, predicting treatment outcome, and understanding the effects of risk genes for the disorder.
Many of these efforts have been complicated by the fact that no central etiopathology is known for the disorder, which is non-uniform in clinical presentation, and overlaps symptomatically with other psychiatric disorders. As well, there are many associated challenges and confounds that add variance to functional imaging data in schizophrenia, including the fact that many patients are chronically ill and routinely take multiple medications known to affect functional brain response. Due to both positive and negative schizophrenia symptoms, they may be unwilling or unable to engage fully with test procedures, especially on complex tasks requiring sustained attention. Much of the existing functional MRI literature is based on blood oxygen level-dependent (BOLD) activation differences gathered during the performance of cognitive tasks, most often those on which patients are known characteristically to perform poorly outside of the scanner. Such an approach has undoubtedly been valuable and produced a large and rich literature. However, none of the fMRI abnormalities recorded in this manner to date has proved diagnostic, and as we discuss below, illness-related performance differences can introduce unavoidable confounds in such task designs.
Keywords
- Type
- Chapter
- Information
- Understanding Neuropsychiatric DisordersInsights from Neuroimaging, pp. 30 - 47Publisher: Cambridge University PressPrint publication year: 2010